Anorectal melanoma is a rare and aggressive malignancy with a poor prognosis. Anorectal melanoma makes up approximately 1 to 3% of all anorectal malignancies. There are no known risk factors for anorectal melanoma. Patients frequently experience a delay in diagnosis due to multiple factors including nonspecific symptoms and misdiagnosis for other benign entities. Anorectal melanoma has a high potential for distant metastases and radiographic imaging plays a key role in evaluating for metastatic disease. Common sites for metastasis include pelvic lymph nodes, lungs, liver, skin, and brain. We present a case report of a 75 year old female with a history of transanal excision of primary anorectal melanoma who presented with increasing abdominal pain and distention. Computed tomography scan of the abdomen and pelvis showed metastatic disease to the peritoneum with findings of extensive peritoneal carcinomatosis, demonstrating the aggressive nature of anorectal melanoma.
CASE REPORT
A 75 year old female presented with a bleeding anal mass 5 years ago. She underwent colonoscopy and biopsy of the anal mass, which led to the diagnosis of anorectal melanoma. She was subsequently treated with transanal excision followed by postoperative radiotherapy and ipilimumab immunotherapy. She was in sustained remission until 1 year ago when she developed a local recurrence of tumor with biopsy results demonstrating malignant infiltration of the lamina propria with immunohistochemical staining positive for S100 and melan A, consistent with recurrent malignant melanoma (Figure 1 and 2). She underwent a second transanal excision of the recurrent disease at this time.
Nine months later the patient felt another enlarging anal mass and had a third transanal excision. A CT of the abdomen and pelvis performed approximately one month prior to the third excision demonstrates no evidence of metastatic disease ( Figure 3 ). Approximately three weeks after the third excision, she presented to the hospital with worsening abdominal pain and distention and loss of appetite. Abdominal radiograph showed signs of ascites with bulging flanks and diffuse increased density of the abdomen (Figure 4 ). Following the third excision, the patient underwent a CT of the abdomen and pelvis, which showed peritoneal thickening with innumerable mesenteric and peritoneal nodules and ascites, compatible with new extensive peritoneal carcinomatosis ( Figures 5-7) . During the patient's hospital course she underwent abdominal ultrasound to evaluate for abdominal paracentesis, which showed peritoneal thickening and nodularity with ascites ( Figure 8 ). Due to the extent of disease spread and poor prognosis, the patient was referred to palliative medicine. She died three weeks after initial presentation to the hospital.
Etiology & Demographics:
Anorectal melanoma is a rare and aggressive disease with a reported incidence of 1 to 3% of all anal tumors [1] . The incidence rate of anorectal melanoma in the United States has been estimated as 2.7 cases per 10 million people per year [2] . Melanomas arise from melanocyte cells which are a derivate of neural crest cells. There are melanocytes located throughout the body including the skin, eyes, and mucosal surfaces. There are numerous melanocytes in the mucosa of the anal canal which explain why melanoma may develop in the anorectal region. Cutaneous melanoma develops when melanocytes are exposed to ultraviolet B light and undergo malignant transformation. The pathogenesis for anorectal carcinoma however is less understood [3] . There are no known risk factors for anorectal melanoma. Anorectal melanoma is the third most common type of melanoma after cutaneous and ocular melanomas. Anorectal melanoma represents less than 1% of all melanomas [4] . The onset of disease typically presents in the 6 th decade of life with some studies reporting a higher prevalence among females [5, 6] .
Clinical & Imaging Findings:
Anorectal melanoma will present with similar clinical symptoms as other rectal disorders including bleeding, constipation, rectal pain, and change in bowel habits. It is often initially misdiagnosed for other benign entities such as hemorrhoids and polyps. Colonoscopy and direct visualization are essential in making the diagnosis [5] . Our patient initially presented with a bleeding anal mass which was biopsy-proven melanoma.
Anorectal melanoma is a highly aggressive neoplasm with approximately 32% of patients presenting with metastatic disease at the time of initial diagnosis. The most common sites of metastasis include the liver, lungs, and brain [7] . We present a case of primary anorectal melanoma with metastasis to the peritoneum resulting in peritoneal carcinomatosis. Peritoneal carcinomatosis represents widespread metastatic disease within the peritoneal cavity. Peritoneal carcinomatosis is typically seen with many organ based malignancies including ovarian tumors and gastrointestinal stromal tumors (GISTs) [8] . CT findings are nonspecific and many nonneoplastic conditions can present in a similar manner. CT imaging of peritoneal carcinomatosis includes multiple heterogeneously, enhancing peritoneal and omental masses representing diffuse neoplastic infiltration. Peritoneal carcinomatosis can also present as large infiltrating masses throughout the omentum known as 'omental caking' [8] . Our patient presented with increasing abdominal pain and distension three weeks status post transanal excision of primary anorectal melanoma. CT scan of the abdomen and pelvis demonstrated extensive peritoneal and omental nodularity with several large intraperitoneal masses, findings compatible with peritoneal carcinomatosis arising from anorectal melanoma. This case report demonstrates the high potential for metastatic disease in patients with primary anorectal melanoma.
Treatment & Prognosis:
The mainstay treatment of anorectal melanoma is surgical resection. There is continual controversy over the most effective method of surgical treatment with either wide local excision (WLE) or abdominal perineal resection (APR) [1] . Due to the rarity of the disease, there is limited data and research comparing the outcomes of the different surgical techniques. A retrospective review shows a shift toward local excision as the surgical treatment for anorectal melanoma [9] . Local excision has benefits of a quicker recovery time and minimal effect on bowel function compared to APR [1, 9] . However, WLE has not proven to a show a significant change in overall outcome compared to APR. One retrospective review demonstrated 75% of patients having recurrent disease irrespective of the extent of surgical excision [9] . Another larger retrospective study demonstrated a survival of 21 months for patients who underwent WLE and 17 months for patients who underwent APR [1, 10] . Given the lack of significant difference in overall outcome and survival, wide local excision seems to be favored, as it is a less invasive technique. Other adjuvant therapies including chemotherapy and radiation have a less clear role in the treatment of anorectal melanoma.
Anorectal melanoma has a poor prognosis with most patients having metastatic disease at the time of initial diagnosis. Patients with anorectal melanoma who have undergone treatment have a mean survival of 20 months. [11] . Anorectal melanoma is highly aggressive with a 5-year survival rate of 6% to 22% [2] .
Differential Diagnosis:
There are many disease processes that can resemble peritoneal carcinomatosis. The main differential diagnoses to consider for peritoneal carcinomatosis include peritoneal lymphomatosis, peritoneal tuberculosis, pseudomyxoma peritonei, peritoneal sarcomatosis, and malignant peritoneal mesothelioma.
Peritoneal Lymphomatosis Peritoneal lymphomatosis represents the spread of aggressive lymphomas to the peritoneum. It is a rare manifestation of lymphoma and is most frequently seen with non-Hodgkin lymphomas. Peritoneal lymphomatosis often shows significant improvement with chemotherapy treatment [12] . CT findings of peritoneal lymphomatosis include bulky thickening of the omentum with peritoneal nodularity and a small amount of ascites. US findings include hypoechoic mesenteric infiltration. On MRI, the peritoneal nodules are characterized by hypointense signal on T1WI and intermediate signal on T2WI. FDG PET/CT findings include diffuse FDG uptake throughout the omental and mesenteric nodules. The key distinguishing radiographic features are extensive lymphadenopathy and confluent mesenteric masses which encase the mesenteric vessels, creating the "sandwich" sign [13] . The masses are typically bulky and homogeneous with less vascularity compared to peritoneal carcinomatosis. Organomegaly is also a common manifestation seen in lymphoma cases, helping to make the diagnosis of peritoneal lymphomatosis.
Peritoneal Tuberculosis Peritoneal tuberculosis comprises approximately 1-3% of tuberculosis cases and represents the sixth most common extra-pulmonary site. Tuberculosis involving the peritoneum is predominantly seen in patients less than 40 years old with an increased prevalence in females [14] . Clinical findings include abdominal pain, fever, gastrointestinal symptoms, and weight loss. Three types of peritoneal tuberculosis have been described: the 'wet' type, the 'fixed fibrotic' type, and the 'plastic' ('dry') type. The 'wet' type will show a large amount of abdominal ascites. The 'fixed fibrotic' pattern will demonstrate discrete omental masses that adhere to the adjacent bowel.
The 'plastic' type appears as diffuse thickening of the omentum and mesentery with fibrous adhesions [13] . If there is significant ascites, radiographs can demonstrate medial displacement of the bowel. On US, the mesentery will appear echogenic and thickened with or without the presence of ascites. MRI findings include diffuse peritoneal thickening with low signal ascites on TIWI and high signal ascites on T2WI. FDG PET/CT images show diffuse increased FDG uptake of the peritoneal masses and nodules. The peritoneal thickening of tuberculosis will typically have a smoother and more organized appearance compared to that seen in peritoneal carcinomatosis.
Calcified mesenteric macronodules are also a common finding associated with peritoneal tuberculosis.
Pseudomyxoma Peritonei Pseudomyxoma peritonei is a rare entity of diffuse intraperitoneal mucinous implants secondary to a ruptured mucinous neoplasm. The estimated incidence is one to two per million per year [15] . Clinical findings include abdominal distention and discomfort.
Imaging findings can be nonspecific and resemble a similar appearance to peritoneal carcinomatosis. However, there are several findings that are characteristic of pseudomyxoma peritonei. One key finding seen on CT imaging is scalloping of the visceral surfaces, commonly the liver surface. Other important findings on CT include loculated intraperitoneal fluid collections and scattered curvilinear calcifications [13, 15] . On US, the peritoneal masses will appear echogenic and scalloping of the visceral surfaces may be present. On MR, the loculated collections are characterized by low signal on T1WI and high signal on T2WI. FDG PET/CT findings include diffuse increased FDG uptake of the peritoneal masses. There will often be a soft tissue mass of the appendix representing the primary mucinous tumor.
Peritoneal Sarcomatosis Peritoneal sarcomatosis is a rare manifestation of peritoneal metastasis seen with sarcoma neoplasms. The most common tumors associated with this peritoneal entity include gastrointestinal stromal tumors (GISTs), liposarcomas, and leiomyosarcomas. CT findings are similar to that of peritoneal carcinomatosis with disseminated soft tissue implants seen throughout the peritoneum and omentum. The peritoneal soft tissue nodules seen with sarcomatosis typically demonstrate a more spherical appearance with increased vascularity. There is also a minimal amount of abdominal ascites seen with sarcomatosis, helping to differentiate from peritoneal carcinomatosis [16, 17] . On US, it is often difficult to appreciate the peritoneal nodules due to a minimal amount of ascites. There are variable signal characteristics of the peritoneal nodules on both T1WI and T2WI. There will be increased FDG uptake of the peritoneal nodules and masses on FDG PET/CT imaging. Peritoneal involvement seen with GISTs will frequently show heterogeneously enhancing, large necrotic masses [16] .
Malignant Peritoneal Mesothelioma
Malignant peritoneal mesothelioma is an aggressive disease with a rapid and fatal course. The most significant risk factor is long-term exposure to asbestosis. There is a higher prevalence of disease in male patients and commonly presents in the fifth and sixth decades. There are several patterns of peritoneal involvement seen on CT imaging. It can present as a dry type, which is characterized by large intraperitoneal masses, diffuse peritoneal nodularity, and minimal ascites. Another pattern termed the wet type will appear as thickening of the peritoneum, omental masses, and ascites. Peritoneal mesothelioma can also present as a combination of both the dry and wet patterns [18] . Abdominal radiographs may show medial displacement of bowel loops if there is a significant amount of ascites present. US findings are variable with peritoneal masses appearing as either hypoechoic or echogenic. On MRI, the peritoneal nodules and masses are characterized by low to intermediate signal on T1WI and high signal on T2WI. FDG PET/CT imaging will demonstrate mild increased FDG uptake of the intraperitoneal nodules and masses. Peritoneal calcifications are uncommonly seen with mesothelioma, however, pleural based calcifications are frequently present. [19] Imaging is essential in evaluating metastatic disease in cases of primary anorectal melanoma with metastases commonly involving the lymphatic system, lungs, skin, and brain. Anorectal melanoma is an aggressive malignancy that can lead to peritoneal carcinomatosis with CT findings of multiple heterogeneously enhancing peritoneal and omental masses, representing diffuse neoplastic infiltration. Findings: Axial contrast-enhanced CT images of the abdomen and pelvis demonstrate diffuse peritoneal thickening and nodularity (yellow arrows) with a large intraperitoneal mass seen in the lower abdomen (blue arrow). There is omental infiltration (green arrow) with diffuse ascites throughout the abdomen and pelvis. Technique: Axial CT; venous phase; mA 120; kV 120; 5.0 mm slice thickness; 100ml Omnipaque 300 
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